Related Experiment Video
Updated: Jul 11, 2026

13:50
Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
[Tuberculosis in patients with HIV infection]
J Uriz1, J Repáraz, J Castiello
1Servicio de enfermedades infecciosas, Hospital de Navarra, Pamplona, 31008, Spain.
Anales Del Sistema Sanitario De Navarra
|November 21, 2007
Summary
Human Immunodeficiency Virus (HIV) infection significantly worsens tuberculosis (TB) outcomes and clinical presentation. Understanding these interactions is crucial for managing co-infected patients and addressing global health challenges.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Context:
- The global spread of Human Immunodeficiency Virus (HIV) has profoundly impacted tuberculosis (TB) epidemiology.
- HIV exacerbates TB progression and reactivation, while TB worsens outcomes for HIV-infected individuals.
- Co-infection presents unique clinical challenges, particularly in resource-limited settings.
Purpose:
- To delineate the differential clinical manifestations of TB in HIV-infected versus non-infected populations.
- To discuss specialized treatment considerations for tuberculosis in the context of HIV co-infection.
- To highlight the increased susceptibility to non-tuberculous mycobacterial (NTM) infections in individuals with Acquired Immunodeficiency Syndrome (AIDS).
Summary:
- HIV infection accelerates TB progression and increases reactivation risk.
- Clinical presentations of TB differ between HIV-positive and HIV-negative individuals.
- Patients with AIDS exhibit heightened susceptibility to invasive NTM diseases, notably Mycobacterium avium complex and Mycobacterium kansasii.
Impact:
- Informing clinical practice for managing TB/HIV co-infection.
- Guiding public health strategies to mitigate the dual burden of these diseases.
- Enhancing understanding of mycobacterial pathogenesis in immunocompromised individuals.
Related Concept Videos
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...